Inside every person's gut, trillions of microorganisms work together like musicians in an invisible orchestra, breaking down food, training the immune system, and influencing health in ways scientists are still discovering. Now, researchers at the University of Vienna in Austria have found better ways to listen to that orchestra — and the findings could eventually help doctors understand and treat diseases ranging from gut disorders to autoimmune conditions.
The team, working from the Bruker Daltonics Center of Excellence for Metaproteomics, developed improved strategies for simultaneously measuring thousands of microbial and host proteins in the gut. Their work was published in the journal Nature Communications.
The challenge, the researchers explained, is that the gut contains an enormous number of different microorganisms. DNA sequencing can tell scientists which microbes are present — like knowing which musicians are in an orchestra and which instruments they can play. But DNA cannot show what those microbes are actually doing at any given moment.
Proteins solve that problem. Proteins are the molecules that carry out the actual work inside cells, and measuring them reveals which microbial functions are truly active. Lead author Feng Xian compared it to hearing not just who is on stage, but what music they are actually playing.
"Metaproteomics allows us to see what microbial communities are actually doing, rather than simply which microbes are present," Xian said.
To find the best methods, the researchers systematically compared five state-of-the-art mass spectrometry approaches using human fecal samples. They identified the strategies that provided the highest sensitivity and most reliable results. The team then tested these methods during the progression and recovery of intestinal inflammation in patients, finding that the best-performing techniques captured coordinated changes between microbial functions and the host's repair response — showing both the music and the audience's reaction.
David Gomez-Varela, director of the Center of Excellence, said the work is already being put to use. The team is collaborating with international clinical partners to study how microbiomes are involved in neurological, metabolic, and autoimmune diseases.
"Developing better technologies is essential if we want to answer the next generation of questions in microbiome research," Gomez-Varela said. "This will transform our understanding of the microbiome's role in human health."